JP2024526836A5 - - Google Patents

Info

Publication number
JP2024526836A5
JP2024526836A5 JP2024503352A JP2024503352A JP2024526836A5 JP 2024526836 A5 JP2024526836 A5 JP 2024526836A5 JP 2024503352 A JP2024503352 A JP 2024503352A JP 2024503352 A JP2024503352 A JP 2024503352A JP 2024526836 A5 JP2024526836 A5 JP 2024526836A5
Authority
JP
Japan
Application number
JP2024503352A
Other languages
Japanese (ja)
Other versions
JP2024526836A (ja
JPWO2023004289A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/073850 external-priority patent/WO2023004289A1/en
Publication of JP2024526836A publication Critical patent/JP2024526836A/ja
Publication of JP2024526836A5 publication Critical patent/JP2024526836A5/ja
Publication of JPWO2023004289A5 publication Critical patent/JPWO2023004289A5/ja
Pending legal-status Critical Current

Links

JP2024503352A 2021-07-19 2022-07-18 Fanci、rad51、およびpbk抗原を標的とするペプチドおよび操作されたt細胞受容体ならびに使用の方法 Pending JP2024526836A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163223450P 2021-07-19 2021-07-19
US63/223,450 2021-07-19
PCT/US2022/073850 WO2023004289A1 (en) 2021-07-19 2022-07-18 Peptides and engineered t cell receptors targeting fanci, rad51, and pbk antigens and methods of use

Publications (3)

Publication Number Publication Date
JP2024526836A JP2024526836A (ja) 2024-07-19
JP2024526836A5 true JP2024526836A5 (https=) 2025-07-25
JPWO2023004289A5 JPWO2023004289A5 (https=) 2025-07-25

Family

ID=84979747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503352A Pending JP2024526836A (ja) 2021-07-19 2022-07-18 Fanci、rad51、およびpbk抗原を標的とするペプチドおよび操作されたt細胞受容体ならびに使用の方法

Country Status (10)

Country Link
US (1) US20250073333A1 (https=)
EP (1) EP4373516A4 (https=)
JP (1) JP2024526836A (https=)
KR (1) KR20240046834A (https=)
CN (1) CN117957012A (https=)
AU (1) AU2022314048A1 (https=)
CA (1) CA3226965A1 (https=)
IL (1) IL310204A (https=)
MX (1) MX2024000941A (https=)
WO (1) WO2023004289A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2134855A4 (en) * 2007-03-12 2011-01-05 Dana Farber Cancer Inst Inc USES OF FANCI AND FANCI MODULATING AGENTS IN PROGNOSIS, DIAGNOSIS AND CANCER THERAPY
KR102127211B1 (ko) * 2011-10-28 2020-06-29 온코세라피 사이언스 가부시키가이샤 Topk 펩티드 및 이를 포함하는 백신
EP3071594A4 (en) * 2013-11-22 2017-05-03 The Board of Trustees of the University of Illionis Engineered high-affinity human t cell receptors
US10130693B2 (en) * 2015-08-28 2018-11-20 Immatics Biotechnologies Gmbh Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
GB201515321D0 (en) * 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
GB201522592D0 (en) * 2015-12-22 2016-02-03 Immunocore Ltd T cell receptors
US20200308279A1 (en) * 2017-10-06 2020-10-01 Oslo Universitetssykehus Hf Chimeric antigen receptors
WO2019196088A1 (en) * 2018-04-13 2019-10-17 Syz Cell Therapy Co. Methods of obtaining tumor-specific t cell receptors
US20240024438A1 (en) * 2020-11-19 2024-01-25 Board Of Regents, The University Of Texas System Methods and compositions comprising mhc class peptides

Similar Documents

Publication Publication Date Title
CL2025003670A1 (es) Calentador con adición remota de aire de combustión.
BR102022025291A2 (https=)
JP2024526836A5 (https=)
CL2025003832A1 (es) Sistema de manipulación de acristalamiento
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13135U (https=)
BY13175U (https=)
CN307046850S (https=)
CN307046267S (https=)
CN307045815S (https=)
CN307045738S (https=)
CN307045723S (https=)
CN307045619S (https=)
CN307044609S (https=)
CN307047331S (https=)